lobbying_activities: 3234172
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3234172 | 7f2e2dfd-2bcd-41d9-911d-27632165474e | Q3 | REINECKE STRATEGIC SOLUTIONS, INC. | 298012 | PHARMAVITE LLC | 2024 | third_quarter | BUD | H.R. 9029/S.4690, Agriculture and Related Agencies Appropriations Act for FY25 specifically for adequate funding for regulation of dietary supplements. H.R. 9020/S.4942FY 2025 Appropriations for Department of HHS, specifically for adequate research and education about menopause and women's health. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2024-10-09T13:03:34-04:00 |